enzyme (R&D Systems)
Structured Review
Enzyme, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 97 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fluorogenic+peptide+substrate/Mca-RPPGFSAFK(Dnp)-OH+Fluorogenic+Peptide+Substrate/pmc07272753-152-17-27
Average 93 stars, based on 97 article reviews
Images
Related Articles
other:Article Title: Cyanidin‐3‐O‐Glucoside Covalent Inhibition of Insulin‐Degrading Enzyme Reveals the Potential Molecular Mechanism for Insulin Resistance Improvement Article Snippet: Mca‐RPPGFSAFK( Article Title: Design of Novel Mercapto-3-phenylpropanoyl Dipeptides as Dual Angiotensin-Converting Enzyme C-Domain-Selective/Neprilysin Inhibitors. Article Snippet: Omapatrilat was purchased from Sigma-Aldrich. Purification:Article Title: Design of Novel Mercapto-3-phenylpropanoyl Dipeptides as Dual Angiotensin-Converting Enzyme C–Domain-Selective/Neprilysin Inhibitors Article Snippet: Purified fully glycosylated human cACE and nACE proteins , were used in fluorogenic end point activity assays utilizing Cbz-Phe-His-Leu (Z-FHL, Bachem Ltd., nACE K m = 600 μM; cACE K m = 60 μM) as the substrate as previously described. .. A purified human NEP ectodomain was used in continuous activity assays utilizing MCA-RPPGFSAFK( Activity Assay:Article Title: Design of Novel Mercapto-3-phenylpropanoyl Dipeptides as Dual Angiotensin-Converting Enzyme C–Domain-Selective/Neprilysin Inhibitors Article Snippet: Purified fully glycosylated human cACE and nACE proteins , were used in fluorogenic end point activity assays utilizing Cbz-Phe-His-Leu (Z-FHL, Bachem Ltd., nACE K m = 600 μM; cACE K m = 60 μM) as the substrate as previously described. .. A purified human NEP ectodomain was used in continuous activity assays utilizing MCA-RPPGFSAFK( Recombinant:Article Title: Exploiting the angiotensin-converting enzyme pathway to augment endogenous opioid signaling Article Snippet: .. Recombinant mouse ACE1 enzyme (Cat# 1513-ZN) and Article Title: Exploiting the angiotensin-converting enzyme pathway to augment endogenous opioid signaling. Article Snippet: .. Recombinant mouse ACE1 enzyme (Cat# 1513-ZN) and Article Title: Exploiting the Angiotensin-Converting Enzyme Pathway to Augment Endogenous Opioid Signaling Article Snippet: .. Recombinant mouse ACE1 enzyme (Cat# 1513-ZN) and |

